Genomic consent: New guideline to help researchers and patients

Feeling poorer than your friends in early adolescence is associated with worse mental health, study finds
15 November 2022
Alzheimer’s drug gantenerumab fails to slow decline in phase III clinical trial
15 November 2022

Genomic consent: New guideline to help researchers and patients

How can Canada optimize the impact of human genomic sequencing to increase our understanding of disease? New guidance in Canadian Medical Association Journal (CMAJ) lays out the key elements for obtaining patient consent for researchers and policymakers in this growing field.

Comments are closed.